Cargando…

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients

BACKGROUND/AIMS: Existing hepatocellular carcinoma (HCC) prediction models are derived mainly from pretreatment or early on-treatment parameters. We reassessed the dynamic changes in the performance of 17 HCC models in patients with chronic hepatitis B (CHB) during long-term antiviral therapy (AVT)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiaoning, Xu, Xiaoqian, Zhou, Jialing, Sun, Yameng, Ding, Huiguo, Xie, Wen, Chen, Guofeng, Ma, Anlin, Piao, Hongxin, Wang, Bingqiong, Chen, Shuyan, Meng, Tongtong, Ou, Xiaojuan, Yang, Hwai-I, Jia, Jidong, Kong, Yuanyuan, You, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366790/ https://www.ncbi.nlm.nih.gov/pubmed/37165622 http://dx.doi.org/10.3350/cmh.2023.0121

Ejemplares similares

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
por: Wu, Xiaoning, et al.
Publicado: (2019)

Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China
por: Zhao, Xinyu, et al.
Publicado: (2022)

SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies
por: Wang, Bingqiong, et al.
Publicado: (2019)

Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy
por: Sun, Yameng, et al.
Publicado: (2018)

Changing clinical care cascade of patients with chronic hepatitis B in Beijing, China
por: Li, Min, et al.
Publicado: (2021)

Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Cheng, Jieyao, et al.
Publicado: (2015)

Noninvasive Evaluation of Liver Fibrosis Reverse Using Artificial Neural Network Model for Chronic Hepatitis B Patients
por: Wei, Wei, et al.
Publicado: (2019)

A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis B
por: Zhou, Jialing, et al.
Publicado: (2016)

Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up
por: Zhang, Wei, et al.
Publicado: (2017)

The Impact of the Definitions of Clinical Phases on the Profiles of Grey-Zone Patients with Chronic Hepatitis B Virus Infection
por: Xu, Xiaoqian, et al.
Publicado: (2023)

Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis
por: Zhang, Qian, et al.
Publicado: (2019)

Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma
por: Teng, Wei, et al.
Publicado: (2019)

A Better Antiviral Efficacy Found in Nucleos(t)ide Analog (NA) Combinations with Interferon Therapy than NA Monotherapy for HBeAg Positive Chronic Hepatitis B: A Meta-Analysis
por: Wei, Wei, et al.
Publicado: (2015)

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity
por: Stauffer, Winston, et al.
Publicado: (2023)

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity
por: Stauffer, Winston, et al.
Publicado: (2023)

GPC-3 in hepatocellular carcinoma: current perspectives
por: Wu, Yongle, et al.
Publicado: (2016)

Single Nucleotide Polymorphisms of Toll-Like Receptor 4 Decrease the Risk of Development of Hepatocellular Carcinoma
por: Minmin, Shi, et al.
Publicado: (2011)

Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma
por: Ou, Qiyun, et al.
Publicado: (2020)

Decreased risk of hepatocellular carcinoma recurrence with direct-acting antivirals compared with no treatment for hepatitis C: a meta-analysis
por: Lui, Felix H., et al.
Publicado: (2020)

Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma
por: Zheng, Xiaoqin, et al.
Publicado: (2021)

Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment
por: Zhang, Dake, et al.
Publicado: (2012)

miR-9875 functions in antiviral immunity by targeting PDCD6 in mud crab (Scylla paramamosain)
por: Gong, Yi, et al.
Publicado: (2020)

Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis
por: Kilany, Shimaa, et al.
Publicado: (2021)

Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B
por: You, Hong, et al.
Publicado: (2016)

Effects of Triple Effective RNA (teRNA) on the Inhibition of Hepatocellular Carcinoma Cells
por: Xue, Yuwen, et al.
Publicado: (2017)

The impact of antiviral therapy on hepatocellular carcinoma epidemiology
por: Colombo, Massimo, et al.
Publicado: (2018)

Antiviral activity of Jinchai capsule against influenza virus
por: Zhong, Juying, et al.
Publicado: (2013)

Development and Effects of Influenza Antiviral Drugs
por: Yin, Hang, et al.
Publicado: (2021)

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
por: Chen, Hongda, et al.
Publicado: (2018)

Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
por: Lin, Wei-Chen, et al.
Publicado: (2020)

FTX271: A potential gene resource for plant antiviral transgenic breeding
por: Zhang, Yuhan, et al.
Publicado: (2022)

Progress in Antiviral Fullerene Research
por: Xu, Piao-Yang, et al.
Publicado: (2022)

Intracellular alpha-fetoprotein interferes with all-trans retinoic acid induced ATG7 expression and autophagy in hepatocellular carcinoma cells
por: Wang, Shanshan, et al.
Publicado: (2021)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
por: Huang, Chung-Feng, et al.
Publicado: (2019)

The TRIM25 Gene in Ducks: Cloning, Characterization and Antiviral Immune Response
por: Liu, Jinlu, et al.
Publicado: (2022)

The development of immunosorbents for the treatment of systemic lupus erythematosus via hemoperfusion
por: Yu, Yameng, et al.
Publicado: (2023)

Examining the Correlation Between Depression and Social Behavior on Smartphones Through Usage Metadata: Empirical Study
por: Wang, Yameng, et al.
Publicado: (2021)

Detecting Depression Through Gait Data: Examining the Contribution of Gait Features in Recognizing Depression
por: Wang, Yameng, et al.
Publicado: (2021)

Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals
por: Nguyen, Kelvin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dddverhcoir2us4hmo0mgl2d4j